Getinge (OTCMKTS:GNGBY) Stock Price Passes Above 50-Day Moving Average – Here’s Why

Getinge (OTCMKTS:GNGBY) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.11 and traded as high as $24.9788. Getinge shares last traded at $24.9788, with a volume of 407 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Getinge from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat.com, Getinge has an average rating of “Strong Buy”.

Getinge Stock Performance

The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.74 and a current ratio of 1.31. The firm’s 50 day moving average is $22.20 and its 200-day moving average is $21.43. The company has a market cap of $6.85 billion, a PE ratio of 23.96 and a beta of 0.92.

Getinge (OTCMKTS:GNGBY) last announced its quarterly earnings data on Friday, July 17th. The company reported $0.38 earnings per share (EPS) for the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. The firm had revenue of $894.87 million during the quarter. On average, research analysts anticipate that Getinge will post 1.38 earnings per share for the current fiscal year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.